Quality & Technology Committee Symposium on Quality Assurance for Sterile Pharmaceuticals and the Latest Trends in GMP Inspections

Date and Time

Saturday, November 16, 2019, 1:00 PM – 5:00 PM, Iino Hall

Program

Click here for the program (238 KB)

Presentation Materials

You can scroll horizontally

Presentation Speakers
Key Points of the Revision to PIC/S GMP Annex 1 01_SUMMARY OF REVISIONS TO ANNEX 1 & Points Discussed During the Revision (3.1MB) Ms. Tracy Moore (UK-MHRA)
Mr. Abdelaali Sarakha (FR-ANSM)
Inspection Perspectives on Sterile Drug Products from Inspectors in the U.S., Europe, and Japan 02_cGMP Inspectional Deficiencies for Sterile Drug Products (1MB) Ms. Ileana Barretto-Pettit (US-FDA)
03_Observation and Inspection Points for Sterile Products (1.9MB) Mr. Abdelaali Sarakha (FR-ANSM)
04_MHRA Inspection Findings - Sterile Products (889KB) Ms. Tracy Moore (UK-MHRA)
05_The Symposium on "PIC/S GMP Annex 1 and Relevant GMP Inspections" (744KB) Mr. Tetsuhito Takarada (JPN-PMDA)
Break
Panel Discussion: “Trends in GMP Inspections” 06_MHRA GMP Inspections (716KB) Ms. Tracy Moore (UK-MHRA)
07_ANSM GMP Inspection Overview (1.7MB) Mr. Abdelaali Sarakha (FR-ANSM)
08_GMP Inspection Overview: U.S. Food and Drug Administration (332KB) Ms. Ileana Barreto-Pettit (US-FDA)
09_The Russian GMP Inspectorate: Inspection Experience and Review of Inspections (1.1MB) Ms. Elena Denisova (RUS-MIT)
Ms. Tatiana Nikolko (RUS-SID&GP)
11_ANVISA and the Brazilian Medicines Inspection System (1.4MB) Ms. Andrea Geyer (BRA-ANVISA)
12_Overview of the PMDA Inspection Process (396KB) Mr. Tetsuhito Takarada (JPN-PMDA)
13_Overview of Saudi FDA GMP Inspections (1.2MB) Mr. Mohammed Ali Dahhas (SAU-SFDA)
 

Share this page

TOP